Arcus Biosciences (RCUS) Accumulated Depreciation & Amortization (2017 - 2024)
Historic Accumulated Depreciation & Amortization for Arcus Biosciences (RCUS) over the last 8 years, with Q4 2024 value amounting to $10.0 million.
- Arcus Biosciences' Accumulated Depreciation & Amortization rose 2500.0% to $10.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $10.0 million, marking a year-over-year increase of 2500.0%. This contributed to the annual value of $10.0 million for FY2024, which is 2500.0% up from last year.
- Latest data reveals that Arcus Biosciences reported Accumulated Depreciation & Amortization of $10.0 million as of Q4 2024, which was up 2500.0% from $8.0 million recorded in Q4 2023.
- Arcus Biosciences' Accumulated Depreciation & Amortization's 5-year high stood at $14.3 million during Q4 2020, with a 5-year trough of $4.0 million in Q4 2021.
- Its 5-year average for Accumulated Depreciation & Amortization is $8.5 million, with a median of $8.0 million in 2023.
- In the last 5 years, Arcus Biosciences' Accumulated Depreciation & Amortization tumbled by 7200.45% in 2021 and then skyrocketed by 5000.0% in 2022.
- Quarter analysis of 5 years shows Arcus Biosciences' Accumulated Depreciation & Amortization stood at $14.3 million in 2020, then crashed by 72.0% to $4.0 million in 2021, then skyrocketed by 50.0% to $6.0 million in 2022, then surged by 33.33% to $8.0 million in 2023, then increased by 25.0% to $10.0 million in 2024.
- Its Accumulated Depreciation & Amortization was $10.0 million in Q4 2024, compared to $8.0 million in Q4 2023 and $6.0 million in Q4 2022.